FDA Approved: RENFLEXIS — Original Application (Organon LLC)

View source ↗

Summary

The FDA approved RENFLEXIS (infliximab) from Organon LLC based on an original application, making it a biosimilar to Remicade. The approval covers indications o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• RENFLEXIS (Infliximab)

Snippet

ORIG AP for RENFLEXIS (INFLIXIMAB)